Product information

From Health Canada

New search

Current status:

Marketed

Current status date:

2018-08-31

Original market date: See footnote 1

2018-08-31

Product name:

ALUNBRIG

Description:

INITIATION PACK

DIN:

02479230 Electronic product monograph is not available

Company: 

TAKEDA CANADA INC
3800  22 Adelaide Street West
Toronto
Ontario
Canada  M5H 4E3

Class: 

Human

Dosage form(s):

Kit,  Tablet

Route(s) of administration:

Oral

Number of active ingredient(s):

2

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

10:00.00   ANTINEOPLASTIC AGENTS

Anatomical Therapeutic Chemical (ATC): See footnote 4

L01ED04  BRIGATINIB

Active ingredient group (AIG) number:See footnote 5

0260491001

List of active ingredient(s)
Active ingredient(s) Strength
BRIGATINIB 180 MG
BRIGATINIB 90 MG

Risk Management Plans See footnote 7

A Risk Management Plan (RMP) for this product was submitted.

Application information

Related information

Contact us

Version 3.9.0
Date modified: